People Power: How The Crowd May Shape The Funding And Development Of Drugs

Companies are sprouting across the pharma value chain that harness the voices of patients and other individual stakeholders to drive the research, development, and financing of drugs. Pharma is taking tentative steps toward using these methods, but high barriers remain to their systematic integration in R&D.

Older concepts of patient empowerment are being overtaken by a potent new idea: that patients – in fact, all citizens interested in contributing to the improvement of health outcomes through innovative therapies – can have a significant voice in the funding and development of medicines.

Companies are sprouting across the pharma value chain that harness various forms of patient input into the research, development, and...

More from Innovation

More from In Vivo